Jeff Yass’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4K | Buy |
+895
| New | +$16.6K | ﹤0.01% | 13124 |
|
|
2026
Q1 | – | Sell |
-475
| Closed | -$10.5K | – | 14123 |
|
|
2025
Q4 | $11.3K | Buy |
+475
| New | +$14K | ﹤0.01% | 12044 |
|
|
2025
Q1 | – | Sell |
-416
| Closed | -$11K | – | 13474 |
|
|
2024
Q4 | $11K | Buy |
+416
| New | +$16.7K | ﹤0.01% | 11978 |
|
|
2024
Q2 | – | Sell |
-452
| Closed | -$27.8K | – | 13255 |
|
|
2024
Q1 | $27.8K | Buy |
+452
| New | +$31.8K | ﹤0.01% | 11738 |
|
|
2023
Q2 | – | Sell |
-98
| Closed | -$13.8K | – | 13154 |
|
|
2023
Q1 | $13.8K | Buy |
+98
| New | +$15.2K | ﹤0.01% | 12142 |
|
|
2022
Q4 | – | Sell |
-77
| Closed | -$13K | – | 13689 |
|
|
2022
Q3 | $13K | Buy |
77
+6
| +8% | +$1.16K | ﹤0.01% | 12733 |
|
|
2022
Q2 | $13K | Sell |
71
-34
| -32% | -$6.23K | ﹤0.01% | 12462 |
|
|
2022
Q1 | $17K | Sell |
105
-47
| -31% | -$8.12K | ﹤0.01% | 12670 |
|
|
2021
Q4 | $33K | Buy |
+152
| New | +$43.1K | ﹤0.01% | 12720 |
|
|
2020
Q4 | – | Sell |
-95
| Closed | -$47.2K | – | 11750 |
|
|
2020
Q3 | $29K | Sell |
95
-22
| -19% | -$7.64K | ﹤0.01% | 10337 |
|
|
2020
Q2 | $38K | Buy |
117
+32
| +38% | +$7.32K | ﹤0.01% | 9820 |
|
|
2020
Q1 | $14K | Buy |
+85
| New | +$13.4K | ﹤0.01% | 10004 |
|
|
2017
Q2 | – | Sell |
-76
| Closed | -$64.6K | – | 9854 |
|
|
2017
Q1 | $68K | Buy |
+76
| New | +$71.3K | ﹤0.01% | 8518 |
|
|
2016
Q4 | – | Sell |
-289
| Closed | -$572K | – | 10166 |
|
|
2016
Q3 | $572K | Buy |
289
+79
| +38% | +$148K | ﹤0.01% | 5829 |
|
|
2016
Q2 | $357K | Sell |
210
-94
| -31% | -$159K | ﹤0.01% | 6682 |
|
|
2016
Q1 | $531K | Buy |
304
+49
| +19% | +$78K | ﹤0.01% | 6296 |
|
|
2015
Q4 | $450K | Buy |
255
+175
| +219% | +$310K | ﹤0.01% | 6968 |
|
|
2015
Q3 | $136K | Buy |
80
+8
| +11% | +$19.3K | ﹤0.01% | 8979 |
|
|
2015
Q2 | $196K | Sell |
72
-115
| -61% | -$299K | ﹤0.01% | 9305 |
|
|
2015
Q1 | $541K | Buy |
187
+2
| +1% | +$5.54K | ﹤0.01% | 6951 |
|
|
2014
Q4 | $485K | Sell |
185
-75
| -29% | -$194K | ﹤0.01% | 7266 |
|
|
2014
Q3 | $713K | Sell |
260
-35
| -12% | -$114K | ﹤0.01% | 6566 |
|
|
2014
Q2 | $1.02M | Buy |
+295
| New | +$1.05M | ﹤0.01% | 6013 |
|
|
2014
Q1 | – | Sell |
-264
| Closed | -$1.04M | – | 9446 |
|
|
2013
Q4 | $994K | Buy |
264
+35
| +15% | +$126K | ﹤0.01% | 5520 |
|
|
2013
Q3 | $748K | Buy |
+229
| New | +$670K | ﹤0.01% | 5784 |
|
Other funds holding TRIB
HAIM
WN
MAWA
IWA
BCM
Jeff Yass's TRIB Position: Q2 2026 in Review
Jeff Yass opened a new position in Trinity Biotech (TRIB) in Q2 2026: 895 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #13124 among its holdings. This is a return to the name: Jeff Yass previously reported a position in TRIB as recently as Q4 2025.
Jeff Yass first reported a position in TRIB in Q3 2013 and has held it in 25 quarters since. The position peaked at $1.02M in Q2 2014. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.
- Jeff Yass held 895 shares of Trinity Biotech worth $10.4K as of Q2 2026.
- Trinity Biotech was a new Jeff Yass position in Q2 2026.
- Trinity Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13124 holding.
- Jeff Yass first reported a position in Trinity Biotech in Q3 2013 and has held it in 25 quarters since.
- Jeff Yass's Trinity Biotech position peaked at $1.02M in Q2 2014.
- 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.